A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction
- PMID: 8468436
- DOI: 10.1097/00004850-199300730-00005
A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction
Abstract
A double-blind parallel-group comparison study of moclobemide versus doxepin in 237 patients with major depression confirmed that moclobemide was equal in efficacy and better tolerated than doxepin. It was less sedating and caused fewer anticholinergic adverse events as measured by the UKU side-effect rating scale. Unexpectedly, moclobemide therapy more often than doxepin resulted in increased sexual desire. An exploratory analysis of UKU-measured symptoms of impaired sexual function prior to commencement of the study revealed that moclobemide more often than doxepin led to an improvement of reduced libido and impaired erection, ejaculation and orgasm. This finding is compatible with the assumption that there is a greater likelihood that the anticholinergic reuptake inhibitor doxepin has a higher risk of impairing sexual function than the non-anticholinergic RIMA moclobemide. A single case report of moclobemide-induced sexual hyperarousal supports the alternative assumption that moclobemide has a specific sexually stimulative effect in depression.
Similar articles
-
[Antidepressants and sexual stimulation: the correlation].Encephale. 1998 May-Jun;24(3):180-4. Encephale. 1998. PMID: 9696909 Review. French.
-
A double-blind comparison of moclobemide and doxepin in depressed general practice patients.Acta Psychiatr Scand. 1995 Aug;92(2):125-31. doi: 10.1111/j.1600-0447.1995.tb09555.x. Acta Psychiatr Scand. 1995. PMID: 7572258 Clinical Trial.
-
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.J Clin Psychiatry. 2000 Apr;61(4):276-81. doi: 10.4088/jcp.v61n0406. J Clin Psychiatry. 2000. PMID: 10830148
-
RIMA--a new concept in the treatment of depression with moclobemide.Int Clin Psychopharmacol. 1993 Jan;7(3-4):123-32. doi: 10.1097/00004850-199300730-00001. Int Clin Psychopharmacol. 1993. PMID: 8468432 Review.
-
An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.Aust N Z J Psychiatry. 1992 Sep;26(3):454-8. doi: 10.3109/00048679209072070. Aust N Z J Psychiatry. 1992. PMID: 1417632 Clinical Trial.
Cited by
-
Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach.J Clin Med. 2019 Oct 7;8(10):1640. doi: 10.3390/jcm8101640. J Clin Med. 2019. PMID: 31591339 Free PMC article. Review.
-
Moclobemide: therapeutic use and clinical studies.CNS Drug Rev. 2003 Spring;9(1):97-140. doi: 10.1111/j.1527-3458.2003.tb00245.x. CNS Drug Rev. 2003. PMID: 12595913 Free PMC article. Review.
-
Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.J Psychiatry Neurosci. 1999 Jan;24(1):45-50. J Psychiatry Neurosci. 1999. PMID: 9987207 Free PMC article.
-
Psychotropic drug-induced sexual function disorders: diagnosis, incidence and management.Drug Saf. 1998 Oct;19(4):299-312. doi: 10.2165/00002018-199819040-00005. Drug Saf. 1998. PMID: 9804444 Review.
-
Moclobemide versus fluoxetine for a major depressive episode.Psychopharmacology (Berl). 1995 Mar;118(2):183-7. doi: 10.1007/BF02245838. Psychopharmacology (Berl). 1995. PMID: 7617806 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical